학술논문

Extension of the Germinal Center Stage of B Cell Development Promotes Autoantibodies in BXD2 Mice
Document Type
Academic Journal
Source
Arthritis & Rheumatism. Oct 01, 2013 65(10):2703-2712
Subject
Language
English
ISSN
0004-3591
Abstract
OBJECTIVE: Regulator of G protein signaling (RGS) proteins inhibit chemokine signaling by desensitizing G protein–coupled receptor signals. This study was undertaken to determine the mechanisms by which RGS13 promotes the generation of pathogenic autoantibodies in germinal centers (GCs), using BXD2-Rgs13 mice. METHODS: RESULTS: In the spleens of BXD2 mice, RGS13 was mainly expressed by GC B cells and was stimulated by IL-17 but not IL-21. IL-17 up-regulated RGS13 in A20 GC cells but not 70Z/3 non-GC B cells. BXD2- Rgs13 mice exhibited smaller GCs and lower AID levels, suggesting lower somatic hypermutation and affinity maturation. However, GC B cells from BXD2- Rgs13 mice showed increased levels of IgM plasmablasts, up-regulation of the genes encoding plasma program, including interferon regulatory factor 4, B lymphocyte–induced maturation protein 1, and X-box binding protein 1 and the p-CREB target genes Fosb and Obf1, and down-regulation of the GC program genes Aid, Pax5, and Bach2 compared to BXD2 mice. BXD2-Rgs13 mice had lower titers of IgG autoantibodies and IgG deposits in the glomeruli, suggesting reduced autoantibody pathogenicity. CONCLUSION